TABLE 1.
Characteristics and amino acid changes in MgrB, PhoP, PhoQ, and PmrB in colistin-resistant strains
| Strain | Source | Colistin usage in VGH | MIC | Capsular type | MLST | mRNA relative fold change (mean ± SD) |
Insertion sites in the mgrB regiona | MgrBb |
PhoPb |
PhoQb |
PmrBb |
||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| pmrHc | pmrKd | mgrBe | 28 | 48 | 3 | 86 | 26 | 150 | 258 | 157 | 256 | 280 | |||||||
| Col4 | Blood | Yes | >2,048 | K64 | ST11 | 9.38 ± 0.30 | Gly | ||||||||||||
| Col7 | Blood | Yes | 1,024 | K64 | ST11 | 4.61 ± 0.16 | Gly | ||||||||||||
| Col20 | Sputum | 2,048 | K64 | ST11 | 4.41 ± 0.08 | Gly | |||||||||||||
| Col21 | Sputum | Yes | 512 | K64 | ST11 | 2.61 ± 0.14 | Gly | ||||||||||||
| Col22 | Sputum | 2,048 | K64 | ST11 | 2.73 ± 0.02 | Gly | |||||||||||||
| Col36 | Sputum | Yes | 2,048 | K64 | ST11 | 2.92 ± 0.13 | Gly | ||||||||||||
| Col44 | Sputum | 512 | K64 | ST11 | 5.66 ± 0.05 | Gly | |||||||||||||
| Col49 | Urine | 128 | K64 | ST11 | 10.92 ± 0.94 | Tyr | Gly | Gly | |||||||||||
| Col38 | Urine | 64 | K64 | ST11 | 25.40 ± 0.67 | Pro | |||||||||||||
| Col13 | Sputum | Yes | 128 | K64 | ST11 | 5.33 ± 0.04 | Deletionf | ||||||||||||
| Col25 | Bile | 64 | K64 | ST11 | 5.35 ± 0.14 | IS10R in coding region (+68 to +76) | |||||||||||||
| Col27 | Sputum | Yes | 128 | K64 | ST11 | 14.68 ± 0.97 | 0.07 ± 0.02 | IS10R in promoter region (−27) | |||||||||||
| Col33 | Sputum | Yes | 128 | K64 | ST11 | 16.52 ± 1.12 | IS10R in coding region (+68 to +76) | ||||||||||||
| Col11 | Sputum | Yes | 64 | K24 | ST15 | 2.16 ± 0.06 | 0.01 ± 0.002 | IS5-like in promoter region (−8)g | |||||||||||
| Col37 | Pus | Yes | 16 | K24 | ST15 | 6.17 ± 0.13 | Tyr | ||||||||||||
| Col40 | Pus | Yes | 64 | K24 | ST15 | 9.04 ± 0.03 | Tyr | Phe | |||||||||||
| Col23 | Urine | Yes | 32 | K54 | ST15 | 2.01 ± 0.02 | Pro | ||||||||||||
| Col28 | Urine | >2,048 | K54 | ST29 | 5.9 ± 0.13 | Phe | |||||||||||||
| Col6 | Urine | Yes | 64 | K62 | ST48 | 3.16 ± 0.16 | Leu | Pro | Leu | ||||||||||
| Col14 | Blood | Yes | 128 | K47 | ST11 | 2.83 ± 0.12 | Deletionf | ||||||||||||
| Col19 | Urine | Yes | 64 | K28 | ST37 | 3.69 ± 0.06 | 0.05 ± 0.004 | IS10R in promoter region (−27) | |||||||||||
| Col26 | Sputum | Yes | 32 | K3 | ST13 | 17.97 ± 0.44 | 0.19 ± 0.02 | IS5-like in promoter region (−34)g | |||||||||||
| Col32 | Sputum | 64 | K1 | ST23 | 21.02 ± 1.85 | IS5-like in coding region (+75 to +83)g | |||||||||||||
| Col24 | Sputum | 32 | Unknown K-type | ST421 | 0.22 ± 0.01 | 10.63 ± 0.69 | Tyr | ||||||||||||
| Col31 | Sputum | Yes | 128 | Unknown K-type | ST421 | 0.42 ± 0.07 | 12.72 ± 0.02 | 0.01 ± 0.001 | IS5-like in promoter region (−35)g | ||||||||||
| Col5 | Pus | 8 | KN3 | ST11-like | 0.34 ± 0.02 | 4.34 ± 1.31 | Gly | ||||||||||||
The nucleotide position aligned with genomic DNA of NTUH-K2044 and IS element-inserted sites.
The amino acid positions of mutations in MgrB, PhoP, PhoQ, and PmrB.
The pmrH mRNA relative fold changes (against NTUH-K2044 strain) of the other 7 colistin-susceptible strains were 0.6 ± 0.02, 1.11 ± 0.02, 1.68 ± 0.11, 0.59 ± 0.04, 1.65 ± 0.07, 0.37 ± 0.01, and 0.9 ± 0.04.
The pmrK mRNA relative fold changes (against NTUH-K2044 strain) of the other 7 colistin-susceptible strains were 4.74 ± 0.69, 0.79 ± 0.28, 1.14 ± 0.51, 6.98 ± 0.82, 0.85 ± 0.08, 3.77 ± 0.78, and 2.01 ± 0.18.
The mgrB mRNA relative fold changes (against NTUH-K2044 strain) of the other 7 colistin-susceptible strains were 0.41 ± 0.06, 1.19 ± 0.17, 1.67 ± 0.64, 0.52 ± 0.11, 1.04 ± 0.13, 0.51 ± 0.03, and 0.66 ± 0.11.
No PCR product was detected, and the deletion site is not known.
The IS5-like elements of Col11, Col26, Col32, and Col31 were 95%, 99%, 95%, and 95% identical to the IS5 element.